B7-H6 (NCR3LG1) is the cellular ligand of the NKp30 activating receptor, expressed on primary tumors and largely absent from normal tissues. B7-H6 is an emerging CAR-T target exploiting NKp30-mediated NK/T cell recognition.
| Catalog No. | Product Name | Conjugate | Size | Price (In USD) |
|---|---|---|---|---|
| GM-Tg-hg-IO012-Ab-3-PE | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(PE) | PE | 25T | |
| GM-Tg-hg-IO012-Ab-3-PE | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(PE) | PE | 100T | |
| GM-Tg-hg-IO012-Ab-3-PE | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(PE) | PE | 500T | |
| GM-Tg-hg-IO012-Ab-3-FITC | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(FITC) | FITC | 25T | |
| GM-Tg-hg-IO012-Ab-3-FITC | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(FITC) | FITC | 100T | |
| GM-Tg-hg-IO012-Ab-3-FITC | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(FITC) | FITC | 500T | |
| GM-Tg-hg-IO012-Ab-3-APC | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(APC) | APC | 25T | |
| GM-Tg-hg-IO012-Ab-3-APC | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(APC) | APC | 100T | |
| GM-Tg-hg-IO012-Ab-3-APC | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(APC) | APC | 500T | |
| GM-Tg-hg-IO012-Ab-3-Biotin | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(Biotin) | Biotin | 25T, 100T, 500T |
| Target | B7-H6 (specific biomarker for human tumor cell (NKp30 ligand)) |
|---|---|
| Species | Humanized |
| Expression platform | Mammalian cell |
| Isotypes | Human IgG |
| Tag | hFc |
| Conjugate | PE / FITC / APC / Biotin |
| Size | 25T / 100T / 500T |
| Purity | >=95% (SDS-PAGE) |
| Bioactivity validation | B7-H6 binding, FACS in B7-H6 level test |
| Application | FACS and other Immunoassay for B7-H6 test |
| Products description | Anti-Human B7-H6/NCR3LG1 monoclonal antibody(mAb)(PE/FITC/APC/Biotin) is a recombinant monoclonal antibody. It specifically recognizes B7-H6 (NKp30 ligand induced on tumor cells, a stress ligand for NK recognition). B7-H6 is a tumor cell (NKp30 ligand) marker. This antibody is validated by FACS for NK-receptor-based CAR/T target assessment. It is recommended for multi-color flow cytometry panels to validate B7-H6 expression for NK-receptor-directed CAR-T screening in CAR-T cell therapy manufacturing, QC and functional assessment. |
| Formulation & Reconstitution | Lyophilized from sterile PBS, pH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |